More Than Half of All Cancer Is Preventable. In a review article published in Science Translational Medicine March 28, 2012, the investigators outline obstacles they say stand in the way of making a huge dent in the cancer burden in the United States and around the world. According to the American Cancer Society, an estimated 1,638,910 new
Read more →When a new drug gets tested, the results of the trials should be published for the rest of the medical world.
Except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark.
In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
Review on clinical studies with cannabis and cannabinoids 2005-2009 Arno Hazekamp, Franjo Grotenhermen Institute Biology Leiden, Leiden University, The Netherlands nova-Institut, Chemiepark Knapsack, Industriestraße, D-50354 Hürth, Germany Abstract To date, a large number of controlled clinical trials have been done evaluating the therapeutic applications of cannabis and cannabis-based preparations. In 2006, an excellent review was
Read more →U.S. Panel Says No to Prostate Screening for Healthy Men! Healthy men should no longer receive a P.S.A. blood test to screen for prostate cancer because the test does not save lives over all and often leads to more tests and treatments that needlessly cause pain, impotence and incontinence in many, a key government health panel has decided.
Read more →
Deutsch
Nederlands
Turkish
Russian
Italiano
Français
Português
العربية